New Publication!

We are happy to present our latest scientific contribution! Our colleagues Andrea Garcia and Bart Heeg collaborated with our partners to estimate the health impact of tafamidis in cardiomyopathy. The publication presents a disease simulation model in Transthyretin amyloid cardiomyopathy, a rare disease with a typically poor prognosis. The model aimed to estimate the impact

Lees meer

Manuscript on unmet needs in IBD patients not treated with biologics published

In our recent publication, the Ingress-Health RWE team, together with clinical experts, analyzed a big German claims dataset with >8 million insured to explore unmet needs in patients with Inflammatory Bowel disease not treated with biologics. The team identified a substantial percentage of patients who suffer from active disease and/or steroid dependency, and the majority

Lees meer